[Effects of the Nifuratel-Nystatin combination in local therapy of cervico-vaginal inflammatory diseases].
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy; D009545:Nifuratel / Q000008:administration & dosage* / Q000627:therapeutic use; D009581:Nitrofurans / Q000008:administration & dosage*; D009761:Nystatin / Q000008:administration & dosage* / Q000627:therapeutic use; D011528:Protozoan Infections / Q000188:drug therapy; D014247:Trichomonas Vaginitis / Q000188:drug therapy; D002575:Uterine Cervicitis / Q000188:drug therapy*; D014627:Vaginitis / Q000188:drug therapy*
D004338:Drug Combinations; D009581:Nitrofurans; D009761:Nystatin; D009545:Nifuratel
Effetti dell'associazione farmacologica Nifuratel/Nystatin nella terapia locale delle affezioni infiammatorie cervico-vaginali.